Versor Investments LP bought a new position in Genesco Inc. (NYSE:GCO - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 12,700 shares of the company's stock, valued at approximately $543,000. Versor Investments LP owned 0.11% of Genesco as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of GCO. Olympiad Research LP purchased a new position in Genesco during the 3rd quarter valued at about $222,000. Empowered Funds LLC boosted its holdings in shares of Genesco by 5.3% during the third quarter. Empowered Funds LLC now owns 58,548 shares of the company's stock worth $1,591,000 after purchasing an additional 2,948 shares during the period. Quest Partners LLC grew its position in Genesco by 54.9% during the third quarter. Quest Partners LLC now owns 1,854 shares of the company's stock valued at $50,000 after purchasing an additional 657 shares in the last quarter. Meeder Asset Management Inc. increased its stake in Genesco by 84.6% in the 3rd quarter. Meeder Asset Management Inc. now owns 8,035 shares of the company's stock valued at $218,000 after buying an additional 3,683 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its position in Genesco by 139.9% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 36,279 shares of the company's stock worth $986,000 after buying an additional 21,158 shares in the last quarter. Hedge funds and other institutional investors own 94.51% of the company's stock.
GCO opened at $36.56 on Friday. The company has a market capitalization of $409.94 million, a PE ratio of -15.05 and a beta of 2.35. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.56 and a quick ratio of 0.32. Genesco Inc. has a fifty-two week low of $23.21 and a fifty-two week high of $44.80. The business has a 50-day moving average of $40.74 and a 200-day moving average of $34.16.
Genesco (NYSE:GCO - Get Free Report) last issued its quarterly earnings data on Friday, December 6th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.30 by $0.31. The firm had revenue of $596.30 million for the quarter, compared to analyst estimates of $577.73 million. Genesco had a negative net margin of 1.13% and a positive return on equity of 0.56%. The company's revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.57 earnings per share. Equities research analysts forecast that Genesco Inc. will post 0.94 EPS for the current fiscal year.
In other Genesco news, VP Daniel E. Ewoldsen sold 4,000 shares of the firm's stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $42.68, for a total transaction of $170,720.00. Following the transaction, the vice president now directly owns 41,358 shares in the company, valued at $1,765,159.44. This trade represents a 8.82 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 7.09% of the stock is owned by company insiders.
Genesco Inc operates as a retailer and wholesaler of footwear, apparel, and accessories in the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Genesco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genesco wasn't on the list.
While Genesco currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.